Bemrist Breezhaler Euroopa Liit - taani - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Enerzair Breezhaler Euroopa Liit - taani - EMA (European Medicines Agency)

enerzair breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Zimbus Breezhaler Euroopa Liit - taani - EMA (European Medicines Agency)

zimbus breezhaler

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Mommox 50 mikrogram/dosis næsespray, suspension Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

mommox 50 mikrogram/dosis næsespray, suspension

sandoz a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Posatex Euroopa Liit - taani - EMA (European Medicines Agency)

posatex

intervet international bv - orbifloxacin, mometason furoate, posaconazole - otologica - hunde - behandling af akut otitis externa og akutte eksacerbationer af recidiverende otitis externa, der er forbundet med bakterier, der er modtagelige for orbifloxacin og svampe, der er modtagelige for posaconazole, især malassezia pachydermatis.